Tumours in path_MMR carriers arise or progress when the remaining wild type MLH1, MSH2, MSH6, or PMS2 allele is deactivated because of a second hit, in line with Knudson’s “Two-hit” hypothesis (41). Here, MSH2 is linked to neoplasm.